Does oxidative stress modulate limb muscle atrophy in severe COPD patients?

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 851-862

  Fermoselle, Clara ^a,c   Rabinovich, Roberto ^b,c   Ausín, Pilar ^a   Puig Vilanova, Ester ^a,c   Coronell, Carlos ^a   Sanchez, Francisco ^a,c   Roca, Josep ^b,c   Gea, Joaquim ^a,c   Barreiro, Esther ^a,c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Muscle protein loss; Oxidative stress; Quadriceps muscle dysfunction; Severe chronic obstructive pulmonary disease; Signalling pathways; Ubiquitin proteasome system

Indexed keywords

ACTIN; ANTIOXIDANT; APOLIPOPROTEIN E2; ATROGIN 1; CARBONATE DEHYDRATASE III; CREATINE KINASE; GLUTATHIONE; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEASOME; SUPEROXIDE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR FKHR; UBIQUITIN;

AGED; ARTICLE; BODY COMPOSITION; CELL SIZE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME METABOLISM; ENZYME SYNTHESIS; FAST MUSCLE; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; LEG MUSCLE; MALE; MOLECULAR MECHANICS; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE INJURY; MYOSITIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN METABOLISM; QUADRICEPS FEMORIS MUSCLE; REGULATORY MECHANISM; SEDENTARY LIFESTYLE; TISSUE LEVEL; TISSUE STRUCTURE; UBIQUITINATION;

AGED; CASE-CONTROL STUDIES; EXTREMITIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE;

EID: 84864859152     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00137211     Document Type: Article

References (43)

1. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 809-813.
2. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62: 115-120.
3. Busquets S, Figueras MT, Fuster G, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 2004; 64: 6725-6731. (Pubitemid 39297935)
4. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18: 39-51. (Pubitemid 38076464)
5. Crul T, Testelmans D, Spruit MA, et al. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem 2010; 25: 491-500.
6. Doucet M, Russell AP, Leger B, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 261-269. (Pubitemid 47195876)
7. Plant PJ, Brooks D, Faughnan M, et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2010; 42: 461-471.
8. Ottenheijm CA, Heunks LM, Li YP, et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 997-1002. (Pubitemid 44684448)
9. McFarlane C, Plummer E, Thomas M, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism. J Cell Physiol 2006; 209: 501-514. (Pubitemid 44484641)
10. Hussain SN, Mofarrahi M, Sigala I, et al. Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 2010; 182: 1377-1386.
11. American Thoracic Society, European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1-S40.
12. Barreiro E, Peinado VI, Galdiz JB, et al. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 2010; 182: 477-488.
13. Barreiro E, Gea J, Corominas JM, et al. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003; 29: 771-778. (Pubitemid 38045945)
14. Barreiro E, de la Puente B, Minguella J, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 1116-1124. (Pubitemid 40663723)
15. Barreiro E, Gea J, Matar G, et al. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2005; 33: 636-642. (Pubitemid 41753140)
16. Barreiro E, Schols AM, Polkey MI, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 2008; 63: 100-107. (Pubitemid 351236469)
17. Barreiro E, Rabinovich R, Marin-Corral J, et al. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 2009; 64: 13-19.
18. Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1664-1669. (Pubitemid 36760681)
19. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004; 169: 1022-1027. (Pubitemid 38543641)
20. Rabinovich RA, Ardite E, Mayer AM, et al. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 2006; 73: 757-761. (Pubitemid 44795921)
21. Rabinovich RA, Bastos R, Ardite E, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007; 29: 643-650. (Pubitemid 46554612)
22. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007; 102: 2389-2397. (Pubitemid 47080773)
23. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, et al. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 2009; 33: 1309-1319.
24. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
25. Coin A, Sergi G, Minicuci N, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin Nutr 2008; 27: 87-94.
26. Montes de Oca M, Loeb E, Torres SH, et al. Peripheral muscle alterations in non-COPD smokers. Chest 2008; 133: 13-18.
27. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19: 626-631. (Pubitemid 34285158)
28. Coronell C, Orozco-Levi M, Mendez R, et al. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24: 129-136. (Pubitemid 39029078)
29. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224. (Pubitemid 16116729)
30. Roca J, Rodriguez-Roisin R, Cobo E, et al. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 1990; 141: 1026-1032. (Pubitemid 20157736)
31. Roca J, Burgos F, Barbera JA, et al. Prediction equations for plethysmographic lung volumes. Respir Med 1998; 92: 454-460. (Pubitemid 28162154)
32. Marin-Corral J, Fontes CC, Pascual-Guardia S, et al. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal 2010; 12: 365-380.
33. Martinez-Caro L, Lorente JA, Marin-Corral J, et al. Role of free radicals in vascular dysfunction induced by high tidal volume ventilation. Intensive Care Med 2009; 35: 1110-1119.
34. Rodriguez DA, Kalko S, Puig-Vilanova E, et al. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med 2012; 52: 88-94.
35. Macgowan NA, Evans KG, Road JD, et al. Diaphragm injury in individuals with airflow obstruction. Am J Respir Crit Care Med 2001; 163: 1654-1659. (Pubitemid 32578772)
36. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30: 1467-1474. (Pubitemid 28465510)
37. Van Helvoort HA, Heijdra YF, Thijs HM, et al. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 2006; 38: 1543-1552. (Pubitemid 44373772)
38. Ottenheijm CA, Heunks LM, Sieck GC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 200-205. (Pubitemid 40981194)
39. Testelmans D, Crul T, Maes K, et al. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 2010; 35: 549-556.
40. Sandri M, Sandri C, Gilbert A, et al. FoxO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412. (Pubitemid 38534545)
41. Man C, Natanek SA, Riddoch-Contreras J, et al. Quadriceps myostatin expression in COPD. Eur Respir J 2010; 36: 686-688.
42. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 1072-1077.
43. Vogiatzis I, Simoes DC, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010; 36: 301-310.